FDA Inspection 1076211 — Robyn Sanders, MD
The FDA completed an inspection of Robyn Sanders, MD on Dec 13, 2018 in Greensboro, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 13, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Greensboro, NC (United States)
Additional Details
Clinical Investigator (CI)